🇺🇸 steroid eye drops in United States
27 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 27
Most-reported reactions
- Injection Site Pain — 4 reports (14.81%)
- Insomnia — 4 reports (14.81%)
- Condition Aggravated — 3 reports (11.11%)
- Ocular Hyperaemia — 3 reports (11.11%)
- Pain — 3 reports (11.11%)
- Autoimmune Disorder — 2 reports (7.41%)
- Delusion — 2 reports (7.41%)
- Drug Ineffective — 2 reports (7.41%)
- Erythema — 2 reports (7.41%)
- Flushing — 2 reports (7.41%)
Other Ophthalmology approved in United States
Frequently asked questions
Is steroid eye drops approved in United States?
steroid eye drops does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for steroid eye drops in United States?
Radboud University Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.